No Data
No Data
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Solventum Corporation's (NYSE:SOLV) Market Cap Dropped by US$358m
Key Insights The considerable ownership by retail investors in Solventum indicates that they collectively have a greater say in management and business strategy The top 25 shareholders own 41% of th
Should You Be Excited About Solventum Corporation's (NYSE:SOLV) 33% Return On Equity?
Solventum Is Maintained at Neutral by B of A Securities
Solventum Is Maintained at Neutral by B of A Securities
B of A Securities Maintains Neutral on Solventum, Lowers Price Target to $60
B of A Securities analyst Travis Steed maintains Solventum (NYSE:SOLV) with a Neutral and lowers the price target from $70 to $60.
Bottom 10 Performing S&P 500 Names as H1 Looks to Close Out This Week